NCT06490679

Brief Summary

Periodontitis is a chronic condition associated with the inflammatory destruction of the periodontal tissues ultimately leading to tooth loss. Clinically, it is identified by key features such as clinical attachment loss (CAL), bleeding upon probing (BOP), and an increase in probing pocket depth (PPD), and/or gingival recession. Periodontitis is mediated by polymicrobial dysbiosis with keystone pathogens affecting the virulence of the entire biofilm community. The removal of this biofilm and its retention factors is the ultimate goal of clinical treatment and oral measures applied. The elimination of the biofilm has traditionally been achieved with the use of either hand instruments or power driven devices. Promoting periodontal health or diminishing bacterial presence and calculus buildup on teeth can be accomplished with the same efficacy whether using manual scalers and curettes or ultrasonic scaling instruments. Both hand and ultrasonic instruments are characterized by being time- consuming and requiring technical skill, often causing patient discomfort and post-treatment pain, including hypersensitivity resulting from the loss of hard tissue when scaling the tooth surface. Ultrasonic instruments tend to leave a rougher surface behind compared to hand instruments. While effective the current techniques all have their disadvantages. The aim of this study is to evaluate changes in probing depth clinically, Bleeding on probing, Clinical attachment level, Plaque index, Calculus index, Patient pain/discomfort, Patient satisfaction, Cost effectiveness, Treatment time and Number of pockets closed after using AIRFLOW® Prophylaxis Master device with erythritol powder.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
46

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2024

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

June 29, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 8, 2024

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2025

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2026

Completed
Last Updated

August 9, 2024

Status Verified

August 1, 2024

Enrollment Period

1.3 years

First QC Date

June 29, 2024

Last Update Submit

August 7, 2024

Conditions

Keywords

Air AbrasiveErythritol

Outcome Measures

Primary Outcomes (1)

  • Change in probing pocket depth

    The PPD will be clinically measured by using UNC 15 periodontal probe from the gingival margin to the depth of the pocket.

    PPD will be taken at baseline, 1 month, 3 months and 6months after the intervention during the follow-up period and will be done by a single calibrated examiner.

Secondary Outcomes (9)

  • Bleeding On Probing

    BoP will be taken at baseline, 1 month, 3 months and 6months after the intervention during the follow-up period and will be done by a single calibrated examiner.

  • Clinical Attachment Level

    CAL gain will be taken at baseline, 3 months and 6 months after the intervention during the follow-up period and will be done by a single calibrated examiner.

  • Plaque index

    PI will be measured baseline, 1 month, 3 months and 6 months after the intervention during the follow-up period and will be done by a single calibrated examiner

  • Calculus index

    CI will be taken at baseline, 1 month, 3 months and 6months after the intervention during the follow-up period and will be done by a single calibrated examiner.

  • Patient pain/discomfort

    Postoperative Pain will be measured after the surgical procedure and 1 month, 3 months and 6 months after the intervention

  • +4 more secondary outcomes

Study Arms (2)

Hand and ultrasonic scalers and curettes

EXPERIMENTAL

Hand and ultrasonic scalers and curettes will be used for supra- and subgingival instrumentation.

Procedure: Hand and ultrasonic scalers and curettes

Electro Medical Systems AIRFLOW® Prophylaxis Master Device With Erythritol Powder

ACTIVE COMPARATOR

Prophylaxis Master Device With Erythritol Powder An erythritol powder will be used by Electro Medical Systems AIRFLOW® Prophylaxis Master Device.

Device: Electro Medical Systems AIRFLOW® Prophylaxis Master Device

Interventions

Combination of ultrasonic and hand instrumentation only. Pockets ≥7 mm will be subgingivally debrided using the piezo device according to manufacturer's instructions, and hand curettes will be used until the operator considers the surfaces to be sufficiently clean and free of deposits.

Hand and ultrasonic scalers and curettes

(a) Disclosure of biofilm with erythrosine, (b) Removal of supragingival and subgingival (up to 10 mm) biofilm and stains with the use of AIRFLOW® Master Piezon® with AIRFLOW® PLUS powder (EMS-Dental, Nyon Switzerland). (c) Supra- and sub-gingival debridement by using the AIRFLOW® Master Piezon® device with Piezon NO PAIN® (EMS-Dental) technology.

Electro Medical Systems AIRFLOW® Prophylaxis Master Device With Erythritol Powder

Eligibility Criteria

Age16 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Systemically healthy patients.
  • Patients with an age range between 16 to 80 years.
  • Patients have a minimum of 20 teeth.
  • Periodontitis patients with at least one residual pocket with a probing depth ranging from 7 to 10 mm.
  • Cooperative patients able and willing to come for follow up appointments.

You may not qualify if:

  • Pregnant and lactation females.
  • Patients reporting systemic conditions (eg: diabetes).
  • Patients with severe or unstable upper respiratory tract infections, chronic bronchitis/asthma.
  • Patients with severe inflammation and/or osteonecrosis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Dentistry, Cairo University

Cairo, Egypt

RECRUITING

MeSH Terms

Conditions

Periodontal PocketPeriodontitisGingival DiseasesGingival Hemorrhage

Condition Hierarchy (Ancestors)

Periodontal DiseasesMouth DiseasesStomatognathic DiseasesOral HemorrhageHemorrhagePathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Hani El-Nahas, Professor

    Cairo University

    STUDY DIRECTOR
  • Omnia Tawfik, Lecturer

    Cairo University

    STUDY CHAIR
  • Mohammad Aldawod, Bachelor

    Cairo University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Mohammad Aldawod, Bachelor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator Mohammad Aldawod

Study Record Dates

First Submitted

June 29, 2024

First Posted

July 8, 2024

Study Start

March 1, 2024

Primary Completion

June 1, 2025

Study Completion

January 1, 2026

Last Updated

August 9, 2024

Record last verified: 2024-08

Locations